US EditionTerumo Announces Medis QFR 3.0 Software for Coronary Physiology Assessment Availability in the United States - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Terumo Announces Medis QFR 3.0 Software for Coronary Physiology Assessment Availability in the United States - Cardiac Interventions Today
April 16, 2025—Terumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), announced that the FDA-cleared Medis Quantitative Flow Ratio (QFR) 3.0 software solution for coronary physiology assessment is available in the United States through its collaboration with Medis Medical Imaging. This milestone builds on the companies’ partnership that commenced in December 2023, noted THO. According to the THO press release, the Medis…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
